Hayley Binch is Head of Medicinal Chemistry, Basel at Hoffman-La Roche. Prior to her current role, Hayley worked Vertex Pharmaceuticals at both the San Diego and Oxford sites, where she worked on a number of kinases and pain targets as well as Cystic Fibrosis. Hayley completed her her PhD at the University of Bristol with Professor Tim Gallagher, followed by postdoctoral research positions at the University of Hamburg in the area of synthetic and enzymatic methodology for complex carbohydrate assembly and at Kings College London in the area of nucleophilic additions to asymmetric vinylphosphonamidates.